The electrocardiogram ecg telemetry devices market has seen considerable growth due to a variety of factors.
• In recent times, the market size for electrocardiogram (ECG) telemetry devices has experienced significant growth. The market, valued at $4.14 billion in 2024 is projected to grow to a worth of $4.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.7%.
The impressive growth recorded during the historic period is a result of several factors including an increase in the aging population, a rise in cardiovascular diseases, a surge in home care monitoring devices, a growing adoption of sedentary lifestyles, and an upsurge in life-threatening conditions.
The electrocardiogram ecg telemetry devices market is expected to maintain its strong growth trajectory in upcoming years.
• Predicted considerable expansion is expected in the electrocardiogram (ECG) telemetry devices market in the next few years, with a projection to soar to a $6.21 billion worth by 2029 considering a compound annual growth rate (CAGR) of 8.4%.
This predicted surge during the forecast period can be linked to rising obesity cases, excessive alcohol and cigarette intake, heightened consciousness on cardiovascular health, the commonness of arrhythmia, and escalating stress levels within the society. Key trends to follow within the forecast period encompasses technological innovation, automated instrument reading of ECG, the incorporation of data analytics, sensor technology, internet of things (IoT), and mobile-computing technology.
The growing prevalence of cardiovascular diseases is anticipated to fuel the expansion of the electrocardiogram (ECG) telemetry devices market in the future. Illnesses impacting the heart and blood vessels like coronary artery disease, heart failure, and stroke, collectively fall under Cardiovascular diseases (CVDs). The surge in these diseases is largely attributed to unhealthy diets, a sedentary lifestyle, smoking, alcohol overconsumption, air pollution, and socio-economic factors including poverty and stress. ECG telemetry devices help augment cardiovascular care through real-time, continuous monitoring, facilitating remote and at-home care, improving the performance of implantable devices, assisting in precise diagnosis and individualized treatment, and enabling swift emergency interventions. For instance, as per the American Heart Association, a non-profit organization based in the U.S., the age-modified death ratio due to cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% rise from 224.4 per 100,000 in 2023. Thus, the escalating prevalence of cardiovascular diseases is fueling the growth of the ECG telemetry devices market.
The electrocardiogram (ECG) telemetry devices market covered in this report is segmented –
1) By Product: Event Monitoring And Mobile Cardiac Telemetry, Implantable Loop Recorders, Other Products
2) By Application: Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, Other Applications
3) By End-User: Hospitals, Home Healthcare
Subsegments:
1) By Event Monitoring And Mobile Cardiac Telemetry: Handheld Event Monitors, Wireless Mobile Cardiac Telemetry Devices, Real-Time Event Monitors, Patch-Based Event Monitors, Mobile ECG Telemetry Systems With Cloud Integration
2) By Implantable Loop Recorders: Subcutaneous Implantable Loop Recorders (ILRs), Wireless Implantable Loop Recorders, Long-Term Monitoring Implantable Loop Recorders, Miniaturized Implantable Loop Recorders, Remote Monitoring Implantable Loop Recorders
3) By Other Products: Holter Monitors, Wireless ECG Monitors, Smart Wearable ECG Devices, Patch-Based ECG Monitors, Portable ECG Telemetry Devices
Leading entities in the electrocardiogram (ECG) telemetry devices market are concentrating on creating highly progressive products like disruptive cardiac monitoring devices. These devices have improved precision, can transmit data in real-time, and are conveniently integrated with mobile health platforms. This aids in superior remote patient management as well as the early identification of cardiovascular occurrences. Disruptive cardiac monitoring devices are extremely innovative in nature, providing consistent heart rhythm monitoring and early recognition of heart irregularities. This enables a prompt diagnosis and treatment of cardiovascular diseases. For example, in March 2022, Biotricity, a company in the United States that specializes in creating inventive remote monitoring devices and healthcare applications, introduced Biotres, a disruptive cardiac monitoring device. Biotres allows for constant three-channel ECG data to improve the recognition of cardiac arrhythmias. The device is devised for extended usage, providing up to 30 days of monitoring along with automated data offloading and wireless connectivity, which significantly slashes the diagnostic turnaround times compared to conventional holter monitors. Biotres, with its easy-to-use design and modular features, is regarded as a disruptive solution in the remote patient monitoring market, thereby catering to the escalating demand for efficient cardiac care.
Major companies operating in the electrocardiogram (ECG) telemetry devices market are:
• Johnson & Johnson
• Medtronic PLC
• Koninklijke Philips N.V.
• GE Healthcare Company
• ZOLL Medical Corporation
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Hill-Rom Services Inc.
• BIOTRONIK
• Nihon Kohden Corporation
• iRhythm Technologies Inc.
• Schiller AG
• CardioNet Inc.
• Preventice Solutions Inc.
• AliveCor Inc.
• Mortara Instrument Inc.
• Medicalgorithmics SA
• Custo med GmbH
• ScottCare Cardiovascular Solutions
• Aerotel Medical Systems Ltd.
• Compumed Inc.
North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiogram (ECG) telemetry devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.